Patritumab deruxtecan, CAS [[2227102-46-5]]

Produktübersicht

• Artikelname: Patritumab deruxtecan, CAS [[2227102-46-5]]
• Artikelnummer: MCE-HY-P99813
• Hersteller Artikelnummer: HY-P99813
• Alternativnummer: MCE-HY-P99813-1MG,MCE-HY-P99813-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: HER3-DXd, U3-1402

Produktbeschreibung

Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity[1].

Produkteigenschaften

• Molekulargewicht: 155238 (average)
• Reinheit: 99.08
• CAS Nummer: [2227102-46-5]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: ADC Related